Tunstall AMAC Announces Dr. Moriah J. Weissman Accepted as Member of ASCO
May 07, 2012 09:30 ET | Tunstall AMAC
NEW YORK, NY--(Marketwire - May 7, 2012) - Tunstall AMAC, a healthcare communication company dedicated to supporting the healthcare community with healthcare communication solutions and advanced...
Semafore Pharmaceuticals to Present SF1126 Clinical Data at ASCO Annual Meeting
May 26, 2011 08:30 ET | Semafore Pharmaceuticals
INDIANAPOLIS, May 26, 2011 (GLOBE NEWSWIRE) -- Semafore Pharmaceuticals today announced that Phase 1 clinical data for SF1126 will be presented at the 47th Annual Meeting of the American Society of...
Report on Phase II Clinical Study of Marshall Edwards' Phenoxodiol in Prostate Cancer to Be Presented at ASCO
May 21, 2010 09:00 ET | Marshall Edwards, Inc.
SAN DIEGO, CA--(Marketwire - May 21, 2010) -  Marshall Edwards, Inc., (NASDAQ: MSHL). An abstract titled "A phase II study of oral phenoxodiol in castrate and non-castrate prostate cancer...
Myrexis, Inc. Logo
Myriad Pharmaceuticals Announces Presentations at 2010 ASCO Annual Meeting
May 20, 2010 18:00 ET | Myrexis, Inc.
SALT LAKE CITY, May 20, 2010 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals Inc. (Nasdaq:MYRX) today announced that it will be reporting data on its lead oncology candidate, Azixa™ (MPC-6827),...
Yale Researchers Present Results of Phase II Phenoxodiol Clinical Trial in Prostate Cancer Patients at ASCO 2009 Genitourinary Cancers Symposium
February 24, 2009 08:00 ET | Marshall Edwards, Inc.
ORLANDO, FL--(Marketwire - February 24, 2009) - Marshall Edwards, Inc. (NASDAQ: MSHL) -- Preliminary results from a Phase II clinical trial of oral phenoxodiol in patients with prostate cancer to be...
Clinical Phase I Study Report of Marshall Edwards' Compound Triphendiol to Be Reported in ASCO Proceedings
May 15, 2008 21:00 ET | Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - May 15, 2008) - An abstract submitted to the Annual Meeting of the American Society of Clinical Oncology (ASCO), May 30-June 3, Chicago, Illinois, entitled "Phase Ia...